Reader TTS

Access through your institution Buy or subscribe boxed-textden Broeder AA _ et al_. (2007) Risk factors for surgical site infections and other complications in elective surgery in patients

with rheumatoid arthritis with special attention for anti-tumor necrosis factor: a large retrospective study. _J Rheumatol_ 34: 689–695 Anti-TNF therapy should be interrupted

perioperatively, until conclusive evidence to the contrary is available This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution

Subscribe to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full

article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs *

Contact customer support REFERENCES * Wendling D _ et al_. (2005) Surgery in patients receiving anti-tumour necrosis factor alpha treatment in rheumatoid arthritis: an observational study on

50 surgical procedures. _Ann Rheum Dis_ 64: 1378–1379 Article  CAS  Google Scholar  * Giles JT _ et al_. (2006) Tumor necrosis factor inhibitor therapy and risk of serious postoperative

orthopaedic infection in rheumatoid arthritis. _Arthritis Rheum_ 55: 333–337 Article  Google Scholar  * Bongartz T (2007) Elective orthopaedic surgery and perioperative DMARD management:

many questions, fewer answers, and some opinions... _J Rheumatol_ 34: 653–655 PubMed  Google Scholar  * Rosandich PA _ et al_. (2004) Perioperative management of patients with rheumatoid

arthritis in the era of biologic response modifiers. _Curr Opin Rheumatol_ 16: 192–198 Article  CAS  Google Scholar  * Pham T _ et al_. (2005) Anti TNF α therapy and safety monitoring.

Clinical tool guide elaborated by the Club Rhumatismes et Inflammations (CRI), section of the French Society of Rheumatology (Societe Francaise de Rhumatologie, SFR). _Joint Bone Spine_ 72

(Suppl 1): S49–50 Google Scholar  Download references ACKNOWLEDGEMENTS The synopsis was written by Rachel Murphy, Assistant Editor, Nature Clinical Practice. AUTHOR INFORMATION Author notes

* Department of Rheumatology, University Teaching Hospital, Franche-Comté University, Boulevard Fleming, 25030 Besançon, France [email protected] AUTHORS AND AFFILIATIONS * and Head

of the Department of Rheumatology at the University Teaching Hospital, D Wendling is a Professor of Rheumatology at the Franche-Comté University, Besançon, France., Daniel Wendling Authors *

Daniel Wendling View author publications You can also search for this author inPubMed Google Scholar ETHICS DECLARATIONS COMPETING INTERESTS The author declares no competing financial

interests. RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Wendling, D. Do patients with RA receiving anti-TNF agents have an increased risk of surgical

site infections?. _Nat Rev Rheumatol_ 3, 432–433 (2007). https://doi.org/10.1038/ncprheum0557 Download citation * Received: 30 April 2007 * Accepted: 01 June 2007 * Published: 03 July 2007 *

Issue Date: August 2007 * DOI: https://doi.org/10.1038/ncprheum0557 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry,

a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative